| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/06/2003 | WO2002044355A9 Protozoan expression systems for lysosomal storage disease genes |
| 02/06/2003 | WO2002028904A3 Human anti-cd40 antibodies |
| 02/06/2003 | WO2002027005A9 Enhanced transfection system |
| 02/06/2003 | WO2002021996A3 Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators |
| 02/06/2003 | WO2002010217A9 Endothelial cell expression patterns |
| 02/06/2003 | WO2001064874A9 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/06/2003 | US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders |
| 02/06/2003 | US20030028006 Cytokine receptor common gamma chain like |
| 02/06/2003 | US20030028004 68730 and 69112, protein kinase molecules and uses therefor |
| 02/06/2003 | US20030028001 Expression vector for use as tool in the generation of insulin |
| 02/06/2003 | US20030027999 143 human secreted proteins |
| 02/06/2003 | US20030027993 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027992 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027989 Nucleotide seq uences coding polypeptide for use in the diagnosis and treatment of cancer |
| 02/06/2003 | US20030027987 Novel polypeptide from Haemophilus paragallinarum and process for preparing the same |
| 02/06/2003 | US20030027986 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027985 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders |
| 02/06/2003 | US20030027776 For detecting, therapy, prophylaxis and/or prognosing disorders related to the tissues where these cancer antigens are expressed |
| 02/06/2003 | US20030027774 For diagnosis and therapy of tuberculosis |
| 02/06/2003 | US20030027754 As pharmaceuticals, diagnostics, biosensors and bioreactors |
| 02/06/2003 | US20030027749 For use in therapy, and diagnostic assays |
| 02/06/2003 | US20030027746 Useful in the development of human therapeutics and diagnostic formulations |
| 02/06/2003 | US20030027358 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 02/06/2003 | US20030027303 Nucleotide sequences coding enzyme inhibitors for use in biological pest control |
| 02/06/2003 | US20030027297 19 human secreted proteins |
| 02/06/2003 | US20030027285 Genetically engineered cells for use in the generation of fluorescent proteins |
| 02/06/2003 | US20030027284 Tumor necrosis factor-gamma |
| 02/06/2003 | US20030027283 Protein l and hybrid proteins thereof |
| 02/06/2003 | US20030027281 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027268 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027261 Novel genes TZap7/A, TZap7/B and TZap7 involved in T cell activation and uses thereof |
| 02/06/2003 | US20030027256 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors |
| 02/06/2003 | US20030027254 Nucleotide sequences coding protein for use in the treatment of alzheimer's disease |
| 02/06/2003 | US20030027253 Nucleotides equences codin polypeptide for use in the treatment of cancer |
| 02/06/2003 | US20030027249 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of non-insulin dependent diadetes mellitus, tumous, infection, skin disorders and inflammatory bowel disease |
| 02/06/2003 | US20030027248 Human cDNAs and proteins and uses thereof |
| 02/06/2003 | US20030027247 Antigen binding unit for use in human diagnostics and therapeutics |
| 02/06/2003 | US20030027246 Prostate protein for use in the diagnosis and treatment of cancer |
| 02/06/2003 | US20030027212 Antibody for use in tissue classification |
| 02/06/2003 | US20030027198 Nucleotide sequences coding polypeptide for use in the treatment of tumors |
| 02/06/2003 | US20030027188 SLC7s as modifiers of the p53 pathway and methods of use |
| 02/06/2003 | US20030027177 Human DNA mismatch repair proteins |
| 02/06/2003 | US20030027164 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain |
| 02/06/2003 | US20030027163 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027162 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030027161 Human cDNAs and proteins and uses thereof |
| 02/06/2003 | US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides |
| 02/06/2003 | US20030027156 Generation of preferential proein; obtain nucleotide sequences, incubate with cells, transform cells, express nucleotide sequences, recover proteins |
| 02/06/2003 | US20030027147 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 02/06/2003 | US20030027146 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders |
| 02/06/2003 | US20030027145 Nucleotide sequences coding polypeptide for use in the treatment of cancer and skin disorders |
| 02/06/2003 | US20030027143 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/06/2003 | US20030026805 Genetic engineering; monoclonal antibody grafted to tumor necrosis factor |
| 02/06/2003 | US20030026800 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases |
| 02/06/2003 | US20030026793 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions |
| 02/06/2003 | US20030026791 Aids therapy; insertion into cell a virus vector |
| 02/06/2003 | CA2455722A1 Fermentation medium and method |
| 02/06/2003 | CA2455360A1 Novel peptides of the respiratory syncytial virus (rsv) g protein and their use in a vaccine |
| 02/06/2003 | CA2452735A1 Method for making acylated polypeptides |
| 02/05/2003 | EP1281770A2 Human brain phosphodiesterase and screening method |
| 02/05/2003 | EP1281760A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 02/05/2003 | EP1281759A1 Method of inhibiting the formation of by-product in the production of genetically modified polypeptide |
| 02/05/2003 | EP1281717A2 Putative ion channel |
| 02/05/2003 | EP1281716A2 Purification process based on enzyme/tagged-peptide binding |
| 02/05/2003 | EP1281404A2 Use of antibodies against the urokinase receptor |
| 02/05/2003 | EP1280904A2 Pain signaling molecules |
| 02/05/2003 | EP1280903A2 Ph domain-interacting protein |
| 02/05/2003 | EP1280900A2 Dendritic cell co-stimulatory molecules |
| 02/05/2003 | EP1280899A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 02/05/2003 | EP1280898A1 Modified es cells and es cell-specific gene |
| 02/05/2003 | EP1280897A2 Regulation of nf-at interacting protein nip 45 variant |
| 02/05/2003 | EP1280896A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 02/05/2003 | EP1280890A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids |
| 02/05/2003 | EP1280823A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/05/2003 | EP1280819A1 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
| 02/05/2003 | EP1280540A1 Modified factor viii |
| 02/05/2003 | EP0804231B1 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 02/05/2003 | EP0574512B1 Redirection of cellular immunity by receptor chimeras |
| 02/05/2003 | CN1395617A A humanized antibody to surface antigen S of hepatitis B virus and preparing method thereof |
| 02/05/2003 | CN1395581A Recombinant antibodies to human IL-1 beta |
| 02/05/2003 | CN1395580A Human cystine knot polypeptide |
| 02/05/2003 | CN1394962A Method for producing human brain-derived neurotrophic factor NDNF by using methanol yeast (pichia pastoris) and its application |
| 02/05/2003 | CN1394960A Method for producing neurotrophon-3 (NT-3) by using methanol yeast (pichia pastoris) and its application |
| 02/05/2003 | CN1394873A Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application |
| 02/05/2003 | CN1100877C Pencillin V. amidohydrrolase gene from fusarium oxysporum |
| 02/05/2003 | CN1100876C DNA encoding human paplilloma virus type 18 |
| 02/05/2003 | CN1100789C Preparation process of gene recombination calcitonin or calcitonin anglog |
| 02/04/2003 | US6515203 Isolated nucleic acid molecule encoding a sucrose dependent sucrose fructosyltransferase; protein that catalyzes glycosidic linkage between fructose units; can be used in making artificial sweeteners. |
| 02/04/2003 | US6515111 Monoclonal antibody which inhibits transendothelial migration of human mononuclear leukocytes |
| 02/04/2003 | US6515110 Multivalent antigen-binding proteins |
| 02/04/2003 | US6515109 A guanine nucleotide exchange factor (GEF) that activates Rho proteins by catalyzing replacement of bound GDP with GTP; ECT2 is involved in the regulation of cytokinesis |
| 02/04/2003 | US6515107 Human metabotropic glutamate receptor 7 subtypes |
| 02/04/2003 | US6515105 Vascular Endothelial Growth Factor binding to extracellular domain of NP-1 (Neuropilin-1); bioactive complexes; mediate useful cell responses or antagonize undesired biological activities; angiogenesis; cell differentiation |
| 02/04/2003 | US6514941 Solubilizing casein in an aqueous solvent and hydrolyzing the solubilized casein with an agent (e.g., a protease) that does not cleave the C6, C7 and C12 peptides, resulting hydrolysate is fractionated |
| 02/04/2003 | US6514939 Mutants of atrial natriuretic factor that are protective for stroke |
| 02/04/2003 | US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 02/04/2003 | US6514754 Of herpesvirus of turkeys (HVT) inserted in a non-essential region of the vector; may be manipulated to provide vaccines |
| 02/04/2003 | US6514745 Oncoprotein protein kinase |
| 02/04/2003 | US6514731 Which incorporate major immunodominant epitopes; antigens provide sensitivity and specificity; Immunoassay |